ZBH vs ZVRA · P/E 23, rev $8.23B vs P/E 6.3, rev $75.9M
Zimmer Biomet Holdings Inc (ZBH) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
ZBH currently screens at market cap $17.13B and trailing P/E 22.9. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the ZBH and ZVRA stock pages for the full models.
Not investment advice.